Congress Nears Deal On Billions In Coronavirus Aid

Lawmakers say they are close to an agreement to provide billions in new coronavirus relief, set to be tied to a massive government funding bill.

Congress is expected to include at least $15 billion in response to the Biden administration’s request for new funding for COVID-19 vaccines, treatments and testing.

Getting a deal on the funds would remove a significant hurdle for passing a government funding bill by Friday night, when lawmakers have to pass legislation or spark a shutdown.

Sen. Roy Blunt (R-Mo.), who has been involved in drafting the bill, said that they were drafting it to include $15 billion.

But that number isn’t locked in, with leadership debating adding more money.

Sen. John Thune (S.D.), the No. 2 Senate Republican, appeared skeptical that it would balloon to $22.5 billion, noting that it wasn’t currently “trending” in that direction.

“I don’t think the number is going to get that high, but then it could,” he said.

Republicans had balked last week over the administration’s request for $22.5 billion, which Democrats had wanted to be emergency spending, meaning it wouldn’t have to be paid for.

“I think that we ought to determine — and we’ve asked the administration — how much unspent money is there. There are billions of dollars unspent,” Sen. Richard Shelby (Ala.), the top Republican on the Senate Appropriations Committee said last week.

But lawmakers and two leadership aides told The Hill on Monday that they had reached an agreement for the coronavirus funding to be paid for.

Thune pointed to unspent state and local government funds that were included in previous coronavirus relief measures as a source for much of the new money in the omnibus bill.

“I think a lot of it will come from there,” he said while noting that the bill was still being finalized.


Source Link

Recommended Articles

White House Leaves One Trump-Era Policy Alone

The Biden administration has gutted many of former President Donald Trump’s health care policies, but there’s one that the White House has yet to touch, Kelly reports. It’s a 2019 rule that expanded individual coverage health reimbursement arrangements, or ICHRAs, which allowed employers to provide tax-exempt subsidies to help workers purchase Obamacare plans. The Biden administration’s ...

Read More

Court Strikes Down HHS Rule that Allowed Insurers to Not Count Copay Assistance

In a major victory for patients who depend on prescription drugs, Judge John D. Bates of the U.S. District Court for the District of Columbia struck down a Trump administration federal rule that allowed health insurers to not count drug manufacturer copay assistance towards a beneficiary’s out-of-pocket costs. The case was brought against the U.S. Department of Health and ...

Read More

Lawmakers, Payers And Providers All Air Grievances With Federal No Surprises Act Implementation

Amid a flurry of partisan roadblocks rolling out across Capitol Hill, representatives on both sides of the aisle came together Tuesday to critique federal agencies’ rollout of the No Surprises Act and throw their support behind court-ordered rewrites of independent dispute resolution (IDR) regulations. During a hearing exploring the “flawed implementation” of the law intended ...

Read More

As Biden Plans To Ban Medical Debt From Credit Scores, Advocates Press For More Change

The dramatic impact of medical debt on credit scores may soon be a thing of the past. On Thursday, the White House announced a plan outlined by the Consumer Financial Protection Bureau (CFPB) to eliminate medical debt from credit reports. The move — which follows an earlier decision from the three main credit bureaus to eliminate paid medical debt, medical ...

Read More